Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
Author:
Publisher
Informa UK Limited
Subject
Gastroenterology,Hepatology
Link
http://www.tandfonline.com/doi/pdf/10.1586/17474124.2016.1140571
Reference83 articles.
1. Functional Bowel Disorders
2. Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
3. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
4. Review article: the economic impact of the irritable bowel syndrome
5. Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review;Archiv der Pharmazie;2024-07-23
2. Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?;Expert Opinion on Drug Metabolism & Toxicology;2024-05-02
3. An anodically pretreated boron-doped diamond electrode surface for square-wave adsorptive stripping voltammetric quantification of the non-absorbable antibiotic rifaximin in the pharmaceutical formulation;Diamond and Related Materials;2023-02
4. Spectrophotometric and biological studies for the interaction of rifaximin with Co, Cu, Fe and vitamin C;Journal of Physics: Conference Series;2022-08-01
5. Rifaximin: unique selective antibiotic for the treatment of gastrointestinal diseases;Meditsinskiy sovet = Medical Council;2021-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3